Follow
Gen Yamada
Gen Yamada
Disease Control and Prevention Center, National Center for Global Health and Medicine
Verified email at hosp.ncgm.go.jp
Title
Cited by
Cited by
Year
Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation
G Yamada, K Hayakawa, N Matsunaga, M Terada, S Suzuki, Y Asai, ...
Epidemiology & Infection 149, e175, 2021
212021
Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission
K Yamamoto, M Suzuki, G Yamada, T Sudo, H Nomoto, N Kinoshita, ...
International Journal of Infectious Diseases 104, 65-72, 2021
162021
Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B. 1.1. 529 lineage) in international travelers to Japan
T Maruki, N Iwamoto, K Kanda, N Okumura, G Yamada, M Ishikane, ...
Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022
142022
Impact of body weight gain on the incidence of nonalcoholic fatty liver disease in nonobese Japanese individuals
G Yamada, Y Hagiwara, T Kimura, Y Takeuchi, K Oba, K Masuda, ...
Official journal of the American College of Gastroenterology| ACG 116 (4 …, 2021
142021
Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan
S Tsuzuki, K Hayakawa, Y Uemura, T Shinozaki, N Matsunaga, M Terada, ...
International Journal of Infectious Diseases 118, 119-125, 2022
132022
Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: the potential contribution to alleviating isolation of COVID-19 …
H Nomoto, K Yamamoto, G Yamada, M Suzuki, N Kinoshita, J Takasaki, ...
Journal of Infection and Chemotherapy 27 (11), 1669-1673, 2021
102021
Multisystem inflammatory syndrome in adult after first dose of mRNA vaccine
Y Miyazato, K Yamamoto, G Yamada, S Kubota, M Ishikane, M Sugiyama, ...
Emerging infectious diseases 28 (4), 870, 2022
92022
Interferon lambda 3 in the early phase of coronavirus disease‐19 can predict oxygen requirement
T Suzuki, N Iwamoto, S Tsuzuki, Y Kakumoto, M Suzuki, S Ashida, ...
European Journal of Clinical Investigation 52 (9), 2022
72022
Diagnostic ability using fatty liver and metabolic markers for metabolic‐associated fatty liver disease stratified by metabolic/glycemic abnormalities
A Okada, G Yamada, T Kimura, Y Hagiwara, S Yamaguchi, KI Kurakawa, ...
Journal of Diabetes Investigation 14 (3), 463-478, 2023
62023
Listeria monocytogenes ankle osteomyelitis in a patient with rheumatoid arthritis on adalimumab: a report and literature review of Listeria monocytogenes osteomyelitis
T Kubota, Y Mori, G Yamada, I Cammack, T Shinohara, S Matsuzaka, ...
Internal Medicine 60 (19), 3171-3176, 2021
62021
External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan
G Yamada, K Hayakawa, Y Asai, N Matsunaga, H Ohtsu, M Hojo, ...
Journal of Infection and Chemotherapy 27 (7), 1043-1050, 2021
62021
Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan
T Suzuki, Y Asai, S Ide, S Fukuda, A Tanaka, Y Shimanishi, K Takahashi, ...
Journal of Infection and Chemotherapy 28 (2), 206-210, 2022
52022
Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease
A Okuhama, M Hotta, M Ishikane, A Kawashima, Y Miyazato, M Terada, ...
Journal of Infection and Chemotherapy 28 (2), 217-223, 2022
52022
Clinical outcomes and epidemiological characteristics of bacteremia in the older Japanese population
K Nakamura, K Hayakawa, S Tsuzuki, S Ide, H Nomoto, T Nakamoto, ...
Journal of Infection and Chemotherapy 29 (10), 971-977, 2023
32023
Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19
N Matsunaga, K Kamata, Y Asai, S Tsuzuki, Y Sakamoto, S Ijichi, ...
Infectious Disease Modelling 7 (3), 526-534, 2022
32022
Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2
H Nomoto, K Yamamoto, E Isaka, Y Miyazato, T Suzuki, T Maruki, ...
Journal of Infection and Chemotherapy 29 (1), 15-19, 2023
22023
Effectiveness of oral cephalexin in antibiotic-course completion for methicillin-susceptible Staphylococcus aureus-induced bacteremic vertebral osteomyelitis
N Okumura, K Hayakawa, K Yamamoto, G Yamada, K Mezaki, ...
BMC Infectious Diseases 23 (1), 307, 2023
12023
Methodological concerns regarding a retrospective study with real-world data on Paxlovid in Israel
S Uchikoba, G Yamada, S Tsuzuki
Clinical Infectious Diseases 75 (12), 2278-2279, 2022
12022
Systemic corticosteroid as an adjunctive treatment for lower respiratory tract infection in children with severe motor and intellectual disabilities
T Nakamoto, T Hoshina, M Ishii, G Yamada, K Kusuhara
Journal of Infection and Chemotherapy 28 (3), 384-388, 2022
12022
Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report
S Ide, S Kutsuna, G Yamada, K Hashimoto, M Abe, M Nagi, M Ujiie, ...
Journal of Infection and Chemotherapy 27 (11), 1658-1661, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20